Description
CAPRELSA IGF::OT::IGF
First action · last action
2014-01-24 · 2014-01-27
Transactions
2
First transaction's obligation
$7,318
Base + all options value (sum of deltas)
$14,636
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P2211D
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-01-24+$7,318= $7,318
- Mod P000012014-01-27+$7,318= $14,636
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-01-24 | +$7,318 | $7,318 | CAPRELSA IGF::OT::IGF |
| Mod P00001· FUNDING ONLY ACTION | 2014-01-27 | +$7,318 | $14,636 | CAPRELSA IGF::OT::IGF |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI FBWCB39K5929)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA24117F0409 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $62,720 | FY2017 |
| VA24916J2992 | 596-LEXINGTON(00596) · 6505 · DRUGS AND BIOLOGICALS | $9,360 | FY2016 |
| VA24816F1925 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $7,567 | FY2016 |
| VA24916J2473 | 626-NASHVILLE (00626) · 6505 · DRUGS AND BIOLOGICALS | $10,442 | FY2016 |
| VA24916J2234 | 596-LEXINGTON(00596) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2016 |
| VA24816F1550 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $7,567 | FY2016 |
Other recipients under 6515 from 460-WILMINGTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24415P0876 | PROAIM AMERICAS, LLC. | 460-WILMINGTON | $57,950 | FY2015 |
| VA24415J1170 | CEPHEID | 460-WILMINGTON | $58,386 | FY2015 |
| VA24414F3335 | BURLINGTON MEDICAL LLC | 460-WILMINGTON | $7,865 | FY2014 |
| VA24414F3190 | OLYMPUS AMERICA INC | 460-WILMINGTON | $63,756 | FY2014 |
| VA24414F2838 | PHOENIX TEXTILE CORPORATION | 460-WILMINGTON | $10,416 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24414F0789_3600_V797P2211D_3600 · retrieved 2026-09-26.